Publication | Closed Access

Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients

Advanced Acral MelanomaEfficacy ComparisonMedicineMelanomaImmunologyAnti-ctla-4 Combination TherapyImmune Checkpoint InhibitorImmunotherapeuticsDermatologyImmunotherapyOncologySkin Cancer